S. Korea Attracts Local Subsidiary Of Italian Drug Maker Bracco
This article was originally published in PharmAsia News
Executive SummaryA South Korean subsidiary of Italy's Bracco Imaging launched operations in the country to provide medical-contrast media. As South Korea's first Italian pharmaceutical firm, Bracco Korea plans to compete with other foreign rivals, including Bayer Schering Pharma and GE Healthcare. Until Bracco's decision to set up shop in South Korea, its products had been marketed by Ilsung Pharmaceutical, a local drug maker. (Click here for more
You may also be interested in...
The first phase of a major trade agreement just signed by the US and China obliges the latter to implement a system linking pharma patent enforcement to marketing authorization procedures as well as to offer patent-term extensions.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.